Results

Total Results: 2,142 records

Showing results for "response".

261. Disposition of Comments for CER 183 Tonsillectomy for OSDB (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
     January 17, 2017 - productid=2423 Published Online: January 17, 2017 2 Commentator & Affiliation Section Comment Response … productid=2423 Published Online: January 17, 2017 3 Commentator & Affiliation Section Comment Response … productid=2423 Published Online: January 17, 2017 4 Commentator & Affiliation Section Comment Response … productid=2423 Published Online: January 17, 2017 5 Commentator & Affiliation Section Comment Response … productid=2423 Published Online: January 17, 2017 6 Commentator & Affiliation Section Comment Response

262. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - One trial had no defined primary endpoint and no placebo response. … The other study was a very small crossover study with a small placebo response. … &productid=2436 Published Online: March 24, 2017 10 Commentator & Affiliation Section Comment Response … &productid=2436 Published Online: March 24, 2017 11 Commentator & Affiliation Section Comment Response … &productid=2436 Published Online: March 24, 2017 12 Commentator & Affiliation Section Comment Response

263. Preventing Complications and Treating Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetic-neuropathy-disposition-170707.pdf
     March 24, 2017 - One trial had no defined primary endpoint and no placebo response. … The other study was a very small crossover study with a small placebo response. … &productid=2436 Published Online: March 24, 2017 10 Commentator & Affiliation Section Comment Response … &productid=2436 Published Online: March 24, 2017 11 Commentator & Affiliation Section Comment Response … &productid=2436 Published Online: March 24, 2017 12 Commentator & Affiliation Section Comment Response

264. Disposition of Comments: CER 228, Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-228-nonopioid-pharm-chronic-pain-comments.pdf
     April 16, 2020 - nonopioid-chronic-pain/research Published Online: April 16, 2020 2 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 3 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 4 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 5 Commentator & Affiliation Section Comment Response … nonopioid-chronic-pain/research Published Online: April 16, 2020 6 Commentator & Affiliation Section Comment Response

265. Comparative Effectiveness Review Disposition of Comments Report: Anxiety in Children (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
     August 31, 2017 - research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response … research-2017/ Published Online: August 31, 2017 Commentator & Affiliation Section Comment Response

266. Hepatitis-C-Treatment-Adherence Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-treatment-adherence_executive.pdf
     September 22, 2011 - Response to HCV treatment is typically defined by surrogate virological measures, such as sustained … viral response (SVR) and early viral response (EVR). … , biochemical response (e.g., alanine transaminase [ALT] level), histological response, and patient … Sustained Viral Response Three studies27,34,35 reported SVR. … Early Viral Response One study35 reported EVR for genotype 1 and genotypes 2/3.

267. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-future_research.pdf
     October 26, 2012 - rates and sustained response rates? … rate and sustained response rate for CDI, harms, time to initial response, duration of CDI therapy … rate and sustained response rate for CDI, harms, time to initial response, duration of CDI therapy … Duration of follow-up of 2 weeks should be sufficient for initial response and 6-8 for sustained response … Duration of follow-up of 2 weeks should be sufficient for initial response and 6-8 for sustained response

268. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - productID=1437 Published Online: April 9, 2013 2 Commentator & Affiliation Section Comment Response … productID=1437 Published Online: April 9, 2013 3 Commentator & Affiliation Section Comment Response … productID=1437 Published Online: April 9, 2013 4 Commentator & Affiliation Section Comment Response … productID=1437 Published Online: April 9, 2013 5 Commentator & Affiliation Section Comment Response … The revised report places a stronger emphasis (partly in response to additional evidence published

269. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
     December 11, 2012 - See response above. … No response Peer Reviewer #2 Introduction acceptable No response Peer Reviewer #3 Introduction Page … Peer Reviewer #4 Introduction Excellent - easy to read No response Peer Reviewer #5 Introduction Page … See response below. … See response below.

270. Cancer-Drugs-Utilization-Cost Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
     January 01, 2011 - Among biologic response modifiers, Bacillus Calmette-Guerin (BCG) was most frequently used. … The use of other biologic response modifiers was extremely limited. … The total Medicare reimbursement for biologic response modifiers of interest in 2009 was nearly $21 … See Figure 4 for biologic response modifier-specific trends in reimbursement over the study period. … The total out-of-pocket expense and total drug cost for biologic response modifiers of interest in

271. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - The placebo response (perhaps in part a response of AUD to repeated BIs of MM)18,19 might markedly increase … We don’t understand how the placebo + medical management (MM) response in COMBINE is related to the … We have revised the abstract to indicate that our meta-analyses for variation in naltrexone response … As noted in our response above, we have included the study in question here. … Genetics polymorphisms and other factors for personalized response is still not ready for clinicians

272. Disposition of Comments for Quality Improvement Interventions To Address Health Disparities (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
     August 27, 2012 - displayproduct Published Online: August 27, 2012 2 Commentator & Affiliation Section Comment Response … displayproduct Published Online: August 27, 2012 3 Commentator & Affiliation Section Comment Response … displayproduct Published Online: August 27, 2012 4 Commentator & Affiliation Section Comment Response … displayproduct Published Online: August 27, 2012 5 Commentator & Affiliation Section Comment Response … Please see prior response.

273. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
     February 01, 2017 - Majumder et al documented similar response rates in terms of pain response and toxicity of treating spinal … did not correlate with previous response to RT nor did it correlate with dose fractionation.12 Patients … The overall pain response for all sites was 45% for SF and 51% forMF. … (%) Complete response (%) Acute toxicity (%) Subsequent EBRT required (%) Survival Studies using … A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of

274. Disposition of Comments for CER 178 Newer Medications for Lower Urinary Tract Symptoms (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/prostatic-hyperplasia-medications_disposition-comments.pdf
     May 26, 2016 - productID=2235 Published Online: May 26, 2016 3 Commentator & Affiliation Section Comment Response … productID=2235 Published Online: May 26, 2016 4 Commentator & Affiliation Section Comment Response … TEP Reviewer #1 Results Page 19, line 3: The dose response looks unusual. … Paragraph 2, the responders had a 19 PERCENTAGE POINT increase in response--not 19%. … If true then this is a critical point in the response rates and should be mentioned and the implications

275. Disposition of Comments for Technical Brief 35: Asthma Self-Management Education Packages (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-35-asthma-self-management-comments.pdf
     April 27, 2020 - https://effectivehealthcare.ahrq.gov/exit-disclaimer/ Summary of Peer Reviewer Comments and Author Response … technical-brief Published Online: April 27, 2020 4 Commentator & Affiliation Section Comment Response … technical-brief Published Online: April 27, 2020 5 Commentator & Affiliation Section Comment Response … technical-brief Published Online: April 27, 2020 6 Commentator & Affiliation Section Comment Response … technical-brief Published Online: April 27, 2020 7 Commentator & Affiliation Section Comment Response

276. Disposition of Comments for CER 177 Agitation Aggression Dementia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-agitation-aggression_disposition-comments.pdf
     March 21, 2016 - Commentator & Affiliation Section Comment Response Peer Reviewer #1 Executive Summary I thought … mailto:mfischer@aplushc.com Commentator & Affiliation Section Comment Response Lynn F. … Commentator & Affiliation Section Comment Response Lynn F. … Commentator & Affiliation Section Comment Response G. … Commentator & Affiliation Section Comment Response G.

277. CER 216 Disposition of Comments Report: Telehealth for Acute and Chronic Care Consultations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-216-telehealth-disposition-comments.pdf
     April 24, 2019 - telehealth-acute-chronic/research Published Online: April 24, 2019 2 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 3 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 4 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 5 Commentator & Affiliation Section Comment Response … May be good to point this out in the response too.

278. CER 216 Disposition of Comments Report: Telehealth for Acute and Chronic Care Consultations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-216-telehealth-disposition-comments.pdf
     April 24, 2019 - telehealth-acute-chronic/research Published Online: April 24, 2019 2 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 3 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 4 Commentator & Affiliation Section Comment Response … telehealth-acute-chronic/research Published Online: April 24, 2019 5 Commentator & Affiliation Section Comment Response … May be good to point this out in the response too.

279. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - For hematologic response, five of six trials comparing darbepoetin to epoetin showed no statistically … Summary of Rates of Hematologic Response, Transfusion, and Thromboembolic Events Parameter Darbepoetin … vs. epoetin Epoetin vs. control Darbepoetin vs. control Hb response rates: Number of studies reporting … (0-30%) Darb: 5% across studies) Epo: 7% (3%-11%) Control: 4% (0-23%) Control: 3% 1 Trials defined response … Seven algorithms combining multiple factors, potentially more useful to predict Hb response, are each

280. Disposition of Comments Report for Interventions for Feeding and Nutrition in Cerebral Palsy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_disposition-comments.pdf
     March 20, 2013 - productID=1426 Published Online: March 20, 2013 2 Commentator & Affiliation Section Comment Response … productID=1426 Published Online: March 20, 2013 3 Commentator & Affiliation Section Comment Response … productID=1426 Published Online: March 20, 2013 4 Commentator & Affiliation Section Comment Response … See response above. … No response needed. TEP Member#4 General General Comments: Impressive scholarly review.